Northern Trust Corp Ocuphire Pharma, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 27,267 shares of OCUP stock, worth $26,721. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,267
Previous 27,267
-0.0%
Holding current value
$26,721
Previous $35,000
25.71%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding OCUP
# of Institutions
47Shares Held
5.21MCall Options Held
12.6KPut Options Held
1.8K-
Bios Capital Management, LP Fort Worth, TX2.48MShares$2.43 Million3.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA992KShares$972,3560.0% of portfolio
-
Geode Capital Management, LLC Boston, MA314KShares$307,7040.0% of portfolio
-
Voss Capital, LLC Houston, TX191KShares$187,1380.02% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il176KShares$172,2570.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...